325172-32-5

Upstream product

• 325172-31-4 (2R,3S,5S)-2-Allyl-5-(tert-butyl-dimethyl-silanyloxy)-1-((1S,5R,7R)-10,10-dimethyl-3,3-dioxo-3λ⁶-thia-4-aza-tricyclo[5.2.1.0^1,5]dec-4-yl)-3-hydroxy-7-(4-methoxy-benzyloxy)-heptan-1-one 
• 325172-40-5 (R)-[1-(4-methoxybenzyloxy)-3-((tert-butyl)dimethylsilyloxy)hex-5-en-3-yloxy]dimethylsilane 
• 325172-30-3 (S)-3-((tert-butyldimethylsilyl)oxy)-5-((4-methoxybenzyl)oxy)pentanal 
• 325172-29-0 (3R)-1-[(4-methoxybenzyl)oxy]hex-5-en-3-ol 
• 128461-65-4 3-(p-methoxybenzyloxy)propanal 
• 325172-41-6 (2R,3S,5S)-2-Allyl-5-(tert-butyl-dimethyl-silanyloxy)-1-((1S,5R,7R)-10,10-dimethyl-3,3-dioxo-3λ⁶-thia-4-aza-tricyclo[5.2.1.0^1,5]dec-4-yl)-7-(4-methoxy-benzyloxy)-3-methoxymethoxy-heptan-1-one 

Downstream Products

• 325172-42-7 toluene-4-sulfonic acid 2-[3-(tert-butyl-dimethyl-silanyloxy)-5-(4-methoxy-benzyloxy)-1-methoxymethoxy-pentyl]-pent-4-enyl ester 
• 325172-33-6 2-Allyl-6-methoxy-benzoic acid (1R,3S,4R)-1-[2-(4-methoxy-benzyloxy)-ethyl]-3-methoxymethoxy-4-methyl-hept-6-enyl ester 
• 312962-27-9 (7R,9S,10R)-4-methoxy-7-[2-(4-methoxy-benzyloxy)-ethyl]-9-methoxymethoxy-10-methyl-7,8,9,10,11,14-hexahydro-6-oxa-benzocyclododecen-5-one 
• 325172-43-8 tert-Butyl-{(1S,3S,4R)-1-[2-(4-methoxy-benzyloxy)-ethyl]-3-methoxymethoxy-4-methyl-hept-6-enyloxy}-dimethyl-silane 
• 325172-27-8 (3S,5S,6R)-1-(4-Methoxy-benzyloxy)-5-methoxymethoxy-6-methyl-non-8-en-3-ol 
• 198482-00-7 (+)-Salicylihalamide A 

Relevant academic research and scientific papers

Revision of the absolute configuration of salicylihalamide A through asymmetric total synthesis

A highly E-selective ring-closing metathesis is the key to building the macrocyclic salicylate core of (+)-salicylihalamide A (1). The synthesis results in a reassignment of the absolute configuration of natural (-)-salicylihalamide A (2), a structurally